Red cell transfusion in elective cardiac surgery patients: Where do we go from here?

British Journal of Anaesthesia

Volumn 102, Issue 3, 2009, Pages 294-296

  Slight, R D ^a   Nzewi, O ^a   McClelland, D B L ^a   Mankad, P S ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; ERYTHROPOIETIN;

CARDIOPULMONARY BYPASS; EDITORIAL; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; EVIDENCE BASED PRACTICE; HEART SURGERY; HEMODILUTION; HEMOGLOBIN DETERMINATION; HUMAN; LUNG FUNCTION; MEDICAL DECISION MAKING; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

EID: 60249096055     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep001     Document Type: Editorial

References (22)

1. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005; 95: 33-42
2. Lundy JS. Clinical Anesthesia - A Manual of Clinical Anesthesiology. Philadelphia: W.B. Saunders Co., 1942; 381
3. Hebert PC, Wells G, Martin C, et al. A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med 1998; 26: 482-7
4. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92: 1646-52
5. Licker M, Ellenberger C, Murith N, et al. Cardiovascular response to acute normovolaemic haemodilution in patients with severe aortic stenosis: assessment with transoesophageal echocardiography. Anaesthesia 2004; 59: 1170-7
6. Spahn DR, Schmid ER, Seifert B, Pasch T. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 1996; 82: 687-94
7. Slight RD, O'Donohoe P, Fung AK, Alonzi C, McClelland DB, Mankad PS. Rationalizing blood transfusion in cardiac surgery: the impact of a red cell volume-based guideline on blood usage and clinical outcome. Vox Sang 2008; 95: 205-10
8. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-16
9. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005; 45 (2 Suppl): 33-9S
10. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma 2006; 60 (6 Suppl): S83-90
11. Despotis GJ, Zhang L, Lublin DM. Transfusion risks and transfusion-related pro-inflammatory responses. Hematol Oncol Clin North Am 2007; 21: 147-61
12. Vamvakas EC, Moore SB. Blood transfusion and postoperative septic complications. Transfusion 1994; 34: 714-27
13. Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically? Hematology 2005; 10 (Suppl 1): 208-14
14. Reeves BC, Murphy GJ. Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Anaesthesiol 2008; 21: 669-73
15. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83 (5 Suppl): S27-86
16. Cotoia A, Kameneva MV, Marascalco PJ, Fink MP, Delude RL. Drag-reducing hyaluronic acid increases survival in profoundly hemorrhaged rats. Shock 2008; June 27 (Epub ahead of print)
17. Licker M, Ellenberger C, Sierra J, et al. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest 2005; 128: 838-47
18. Carless PA, Henry DA, Moxey AJ, et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006: CD001888
19. Slight RD, Bappu NJ, Nzewi OC, et al. Perioperative red cell, plasma, and blood volume change in patients undergoing cardiac surgery. Transfusion 2006; 46: 392-7
20. Birkmeyer JD, AuBuchon JP, Littenberg B, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994; 57: 161-8
21. Mosa MM, Cheng DC. Oxygen therapeutics (blood substitutes) in cardiac surgery. Curr Opin Anaesthesiol 2003; 16: 21-6
22. Kocian R, Spahn DR. Haemoglobin, oxygen carriers and perioperative organ perfusion. Best Pract Res Clin Anaesthesiol 2008; 22: 63-80